| Peer-Reviewed

Effect of Intravenous Tranexamic Acid as an Adjunct Haemostat with Pericervical Tourniquet on Perioperative Blood Loss Following Open Abdominal Myomectomy

Received: 4 February 2022     Accepted: 1 March 2022     Published: 18 March 2022
Views:       Downloads:
Abstract

Uterine fibroid is a common gynaecological tumour. Abdominal myomectomy is a common surgical treatment for these women. Open abdominal Myomectomy is associated with significant risk of hemorrhage and the need for perioperative homologous blood transfusion with its potential risks, complications and cost. Tranexamic acid is a synthetic lysine derivative with antifibrinolytic activity used in other surgical disciplines to reduce blood loss during surgery. Its efficacy in reducing blood loss when used as an adjunct to pericervical tourniquet has not been elucidated. In a double blind, placebo-controlled trial, we assessed the effect of intravenous tranexamic acid as an adjunct haemostat with pericervical tourniquet on perioperative blood loss following open abdominal myomectomy in 132 ASA I-II women, aged 18–65 years, who had abdominal myomectomy. The patients were randomly allocated to receive either intravenous Tranexamic acid 1gm (n=66) or placebo (n=66) pre-operatively on arrival in theatre immediately after securing an IV access. All the patients also had a peri-cervical tourniquet applied intraoperatively to secure haemostasis. The volume of intraoperative blood loss, haemodynamic changes associated with blood loss and the complications associated with the use of tranexamic acid were evaluated during the first 72 hours following surgery. One hundred and thirty one (131) patients completed the study; Tranexamic acid group 66 and placebo group 65. One patient in the placebo group had uncontrollable postoperative haemorrhage. This necessitated her having total abdominal hysterectomy. She was thus disqualified from the study. Blood loss was significantly lower in the tranexamic acid group. Mean intraoperatively mean arterial pressure (MAP) compared to baseline was lower in the placebo while the mean intraoperative pulse rate compared to the baseline was higher in the placebo group. The only notable perioperative complication was nausea and vomiting. There was no difference in occurrence of complications between the groups. This study shows that intravenous tranexamic acid as an adjunct haemostat with pericervical tourniquet reduced blood loss, provide better haemodynamic stability with acceptable side effects during abdominal myomectomy.

Published in International Journal of Anesthesia and Clinical Medicine (Volume 10, Issue 1)
DOI 10.11648/j.ijacm.20221001.12
Page(s) 8-15
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

Uterine Fibroid, Myomectomy, Blood Loss, Tranexamic Acid, Peri-cervical Tourniquet

References
[1] Kwawukume EY. Uterine Leiomyomas, In: Kwawukume EY, Emuveyan EE (Eds), Comprehensive Gynaecology in the Ttropics. 1st Edition. Accra, Asante and Hitscher. 2005. 124 137.
[2] George A, Catherine A, Philippe-Yves L, Nicholas L. The management of uterine leiomyomas. J Obstet Gynaecol Can 2015; 37 (2): 157-178.
[3] Aamir T K, Manjeet S, Janesh K G. Uterine fibroids: current perspectives. Int J Womens Health. 2014; 6: 95-114.
[4] Ikechebelu JI, Ezeama CO, Obiechina NJA. The use of tourniquet to reduce blood loss at myomectomy. Niger J Clin Pract 2010; 13 (2): 154-158.
[5] Mairiga AG, Bako BG, Kawuwa MB. Uterine fibroids: A 5 year clinical experience at the University of Maiduguri Teaching hospital, Maiduguri. Borno Med J 2006; 3: 1-4.
[6] Adesina KT, Owolabi BO, Hadijat O. Raji H, Adebunmi O. Olarinoye AO; Abdominal myomectomy: A retrospective review of determinants and outcomes of complications at the University of Ilorin Teaching Hospital, Ilorin, Nigeria. Malawi Medical Journal 2017; 29 (1): 37-42.
[7] Okogbo FO, Ezechi OC, Loto OM, Ezeobi PM. Uterine leiomyomata in South Western Nigeria: a clinical study of presentations and management outcome. Afr Health Sci. 2011; 11 (2): 271-278.
[8] West S, Ruiz R, Parker WH. Abdominal myomectomy in women with very large uterine size. Fertil Steril 2006; 85: 36-39, doi: 10.1016/j.fertnstert.2005.05.073.
[9] Fiebig E. Safety of the blood supply. Clin Orthop Relat Res. 1998; 357: 6–18.
[10] Goel R, Tobian AAR, Shaz BH. Noninfectious transfusionassociated adverse events and their mitigation strategies. Blood 2019; 133: 1831-9.
[11] Rhode JM, Dimcheff DE, Blumberg N, et al. Healthcare-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 2014; 311 (13): 1317-1326.
[12] Kongnyuy EJ, Wiysonge CS. Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database of Systematic Reviews 2014; (8): CD005355. DOI: 10.1002/14651858.CD005355.pub5.
[13] Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999; 57: 1005-1032.
[14] Besser V, Albert A, Sixt SU, et al. Fibrinolysis and the influence of tranexamic acid dosing in cardiac surgery. J Cardiothorac Vasc Anesth 2020; 34: 2664–73.
[15] Charoencholvanich K, Siriwattanasakul P. Tranexamic Acid Reduces Blood Loss and Blood Transfusionafter TKA Clin Orthop Relat Res (2011) 469: 2874–2880 DOI 10.1007/s11999-011-1874-2.
[16] Stewart EA. Uterine fibroids. Lancet2001; 357: 293–8.
[17] Atombosoba AE, Lucky OL, Chukwuemeka AI, Israel J, Isa AI. Review of the clinical presentation of uterine fibroid and the effect of therapeutic intervention on fertility. Am J Clin Med Res, 2015; 3 (1), pp 9-13. DOI: 10.12691/ajcmr-3-1-2.
[18] Nahla W, Hany F, Huda F. Reducing blood loss during open myomectomy with intravenous versus topical tranexamic acid: A double-blinded randomized placebo-controlled trial. Middle East Fertil Soc J. 23 (2018) 225-231.
[19] Panagiotis P, Anna K. Tranexamic acid for the management of uterine fibroid tumours: A systematic review of the current evidence. World J Clin Cases 2014 December 16; 2 (12): 893-898.
[20] Shaaban M, Ahmed M, Farhan R, Dardeer H. Efficacy of Tranexamic Acid on Myomectomy-Associated Blood Loss in Patients with Multiple Myomas: A Randomized Controlled Clinical Trial. Reprod Sci 2016 07 29; 908-912.
[21] Caglar GS, Tasci Y, Kayikcioglu F, Haberal A. Intravenous tranexamic acid use in myomectomy: A prospective randomized double-blind controlled study. Eur J Obstet Gynaecol Reprod Biol. 2008 Apr; 137 (2): 227-231.
[22] Fletcher H, Frederick J, Hardie M, Simeon D. A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy. Obstet Gynaecol. 1996 Jun; 87 (6): 1014-8.
[23] Marquad KL, Rivlin ME, helmow D. Gynecolgoic Myomectomy: Treatment and Management. Medscape. 2011 article 267–677. [Google Scholar].
[24] Chen H, Qu M, Lian B, Dong Z, Wang Y, Zhu F, Sun Y, Gao X, Experience of one single surgeon with the first 500 robot-assisted laparoscopic prostatectomy cases in mainland China. Asian J Urol 2020; 7 (2): 170-176.
[25] Shah A, Palmer AJR, Klein AA. Strategies to minimize intraoperative blood loss during major surgery. BJS 2020; 107: e26–e38.
Cite This Article
  • APA Style

    Asudo Felicia Dele, Okonkwo Azubuike Venatius, Isamade Erdoo Suckie, Abdullahi Ibrahim Habib. (2022). Effect of Intravenous Tranexamic Acid as an Adjunct Haemostat with Pericervical Tourniquet on Perioperative Blood Loss Following Open Abdominal Myomectomy. International Journal of Anesthesia and Clinical Medicine, 10(1), 8-15. https://doi.org/10.11648/j.ijacm.20221001.12

    Copy | Download

    ACS Style

    Asudo Felicia Dele; Okonkwo Azubuike Venatius; Isamade Erdoo Suckie; Abdullahi Ibrahim Habib. Effect of Intravenous Tranexamic Acid as an Adjunct Haemostat with Pericervical Tourniquet on Perioperative Blood Loss Following Open Abdominal Myomectomy. Int. J. Anesth. Clin. Med. 2022, 10(1), 8-15. doi: 10.11648/j.ijacm.20221001.12

    Copy | Download

    AMA Style

    Asudo Felicia Dele, Okonkwo Azubuike Venatius, Isamade Erdoo Suckie, Abdullahi Ibrahim Habib. Effect of Intravenous Tranexamic Acid as an Adjunct Haemostat with Pericervical Tourniquet on Perioperative Blood Loss Following Open Abdominal Myomectomy. Int J Anesth Clin Med. 2022;10(1):8-15. doi: 10.11648/j.ijacm.20221001.12

    Copy | Download

  • @article{10.11648/j.ijacm.20221001.12,
      author = {Asudo Felicia Dele and Okonkwo Azubuike Venatius and Isamade Erdoo Suckie and Abdullahi Ibrahim Habib},
      title = {Effect of Intravenous Tranexamic Acid as an Adjunct Haemostat with Pericervical Tourniquet on Perioperative Blood Loss Following Open Abdominal Myomectomy},
      journal = {International Journal of Anesthesia and Clinical Medicine},
      volume = {10},
      number = {1},
      pages = {8-15},
      doi = {10.11648/j.ijacm.20221001.12},
      url = {https://doi.org/10.11648/j.ijacm.20221001.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijacm.20221001.12},
      abstract = {Uterine fibroid is a common gynaecological tumour. Abdominal myomectomy is a common surgical treatment for these women. Open abdominal Myomectomy is associated with significant risk of hemorrhage and the need for perioperative homologous blood transfusion with its potential risks, complications and cost. Tranexamic acid is a synthetic lysine derivative with antifibrinolytic activity used in other surgical disciplines to reduce blood loss during surgery. Its efficacy in reducing blood loss when used as an adjunct to pericervical tourniquet has not been elucidated. In a double blind, placebo-controlled trial, we assessed the effect of intravenous tranexamic acid as an adjunct haemostat with pericervical tourniquet on perioperative blood loss following open abdominal myomectomy in 132 ASA I-II women, aged 18–65 years, who had abdominal myomectomy. The patients were randomly allocated to receive either intravenous Tranexamic acid 1gm (n=66) or placebo (n=66) pre-operatively on arrival in theatre immediately after securing an IV access. All the patients also had a peri-cervical tourniquet applied intraoperatively to secure haemostasis. The volume of intraoperative blood loss, haemodynamic changes associated with blood loss and the complications associated with the use of tranexamic acid were evaluated during the first 72 hours following surgery. One hundred and thirty one (131) patients completed the study; Tranexamic acid group 66 and placebo group 65. One patient in the placebo group had uncontrollable postoperative haemorrhage. This necessitated her having total abdominal hysterectomy. She was thus disqualified from the study. Blood loss was significantly lower in the tranexamic acid group. Mean intraoperatively mean arterial pressure (MAP) compared to baseline was lower in the placebo while the mean intraoperative pulse rate compared to the baseline was higher in the placebo group. The only notable perioperative complication was nausea and vomiting. There was no difference in occurrence of complications between the groups. This study shows that intravenous tranexamic acid as an adjunct haemostat with pericervical tourniquet reduced blood loss, provide better haemodynamic stability with acceptable side effects during abdominal myomectomy.},
     year = {2022}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Effect of Intravenous Tranexamic Acid as an Adjunct Haemostat with Pericervical Tourniquet on Perioperative Blood Loss Following Open Abdominal Myomectomy
    AU  - Asudo Felicia Dele
    AU  - Okonkwo Azubuike Venatius
    AU  - Isamade Erdoo Suckie
    AU  - Abdullahi Ibrahim Habib
    Y1  - 2022/03/18
    PY  - 2022
    N1  - https://doi.org/10.11648/j.ijacm.20221001.12
    DO  - 10.11648/j.ijacm.20221001.12
    T2  - International Journal of Anesthesia and Clinical Medicine
    JF  - International Journal of Anesthesia and Clinical Medicine
    JO  - International Journal of Anesthesia and Clinical Medicine
    SP  - 8
    EP  - 15
    PB  - Science Publishing Group
    SN  - 2997-2698
    UR  - https://doi.org/10.11648/j.ijacm.20221001.12
    AB  - Uterine fibroid is a common gynaecological tumour. Abdominal myomectomy is a common surgical treatment for these women. Open abdominal Myomectomy is associated with significant risk of hemorrhage and the need for perioperative homologous blood transfusion with its potential risks, complications and cost. Tranexamic acid is a synthetic lysine derivative with antifibrinolytic activity used in other surgical disciplines to reduce blood loss during surgery. Its efficacy in reducing blood loss when used as an adjunct to pericervical tourniquet has not been elucidated. In a double blind, placebo-controlled trial, we assessed the effect of intravenous tranexamic acid as an adjunct haemostat with pericervical tourniquet on perioperative blood loss following open abdominal myomectomy in 132 ASA I-II women, aged 18–65 years, who had abdominal myomectomy. The patients were randomly allocated to receive either intravenous Tranexamic acid 1gm (n=66) or placebo (n=66) pre-operatively on arrival in theatre immediately after securing an IV access. All the patients also had a peri-cervical tourniquet applied intraoperatively to secure haemostasis. The volume of intraoperative blood loss, haemodynamic changes associated with blood loss and the complications associated with the use of tranexamic acid were evaluated during the first 72 hours following surgery. One hundred and thirty one (131) patients completed the study; Tranexamic acid group 66 and placebo group 65. One patient in the placebo group had uncontrollable postoperative haemorrhage. This necessitated her having total abdominal hysterectomy. She was thus disqualified from the study. Blood loss was significantly lower in the tranexamic acid group. Mean intraoperatively mean arterial pressure (MAP) compared to baseline was lower in the placebo while the mean intraoperative pulse rate compared to the baseline was higher in the placebo group. The only notable perioperative complication was nausea and vomiting. There was no difference in occurrence of complications between the groups. This study shows that intravenous tranexamic acid as an adjunct haemostat with pericervical tourniquet reduced blood loss, provide better haemodynamic stability with acceptable side effects during abdominal myomectomy.
    VL  - 10
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Department of Anaesthesia and Intensive Care, University of Abuja Teaching Hospital, Gwagwalada, Nigeria

  • Department of Anaesthesia and Intensive Care, University of Abuja Teaching Hospital, Gwagwalada, Nigeria

  • Department of Anaesthesia, Jos University Teaching Hospital, Jos, Nigeria

  • Department of Obstetrics and Gynaecology, University of Abuja Teaching Hospital, Gwagwalada, Nigeria

  • Sections